title: Screening for pharmacologic inhibitors of amyloid fibril formation.
authors.affiliation: Department of Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105-1047, USA.
authors.forename: H
authors.initials: H
authors.lastname: LeVine
authors.forename: J D
authors.initials: JD
authors.lastname: Scholten
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D016229:Amyloid beta-Peptides / Q000032:analysis / Q000037:antagonists & inhibitors*; D016477:Artifacts; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D046911:Macromolecular Substances; D010446:Peptide Fragments / Q000032:analysis
chemical_list: D016229:Amyloid beta-Peptides; D046911:Macromolecular Substances; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40)